(Q41343381)

29 September 2017

title

Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells (English)

1 reference

29 September 2017

I N Singh

1

1 reference

29 September 2017

D G McCartney

series ordinal

2

1 reference

29 September 2017

J N Kanfer

series ordinal

3

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 May 1995

1 reference

29 September 2017

1 reference

29 September 2017

volume

365

1 reference

29 September 2017

issue

2-3

1 reference

29 September 2017

page(s)

125-128

1 reference

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Vitamin E protects nerve cells from amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Enzymatic activities during differentiation of the human neuroblastoma cells, LA-N-1 and LA-N-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

U73122 inhibits phospholipase C-dependent calcium mobilization in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Analysis of magnetic resonance spectra by mole percent: comparison to absolute units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

Impaired phosphoinositide hydrolysis in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0014-5793%2895%2900432-9

10.1016/0014-5793(95)00432-9

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference